← FDA DRUG APPROVALS

FDA ANDA · ANDA062854

AMOXICILLIN

Sponsor: TEVA

APPLICATION
ANDA062854
TYPE
ANDA
ORIGINAL APPROVAL
1987-12-22
LATEST ACTION
2000-02-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 500MG · CAPSULE · ORAL

Approval history

2000-02-01Labeling · Supplement 14AP
1999-07-07Labeling · Supplement 12AP
1998-11-10Manufacturing (CMC) · Supplement 11AP
1998-03-17Manufacturing (CMC) · Supplement 10AP
1997-11-05Manufacturing (CMC) · Supplement 9AP
1995-04-05Manufacturing (CMC) · Supplement 6AP
1994-07-19Manufacturing (CMC) · Supplement 8AP
1994-07-19Manufacturing (CMC) · Supplement 7AP
1993-03-29Manufacturing (CMC) · Supplement 4AP
1993-03-29Manufacturing (CMC) · Supplement 5AP
1992-03-24Manufacturing (CMC) · Supplement 3AP
1988-02-25Manufacturing (CMC) · Supplement 1AP
1987-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →